Sartorius has launched the iQue® 5 High-Throughput Screening Cytometer, designed for speed, flexibility and simplified operation. The platform features 27 channels, continuous 24-hour runtime, automated clog detection, and enhanced Forecyt® software.

Aptamer validates targeted RNA delivery to liver fibrosis cells using its Optimer platform and a novel HSC marker.

Enhanced Genomics partners with ALBORADA Drug Discovery Institute to identify novel Alzheimer’s drug targets using 3D multi-omics.

Brenus Pharma and InSphero presented at EACR 2025 data confirming that 3D tumor spheroids are an effective model for testing STC1010 in colorectal cancer.

Waters Corporation has announced the release of the Alliance iS HPLC System Software version 2.0, a significant advancement that delivers comprehensive, end-to-end traceability and enhanced data security for the pharmaceutical industry.

Thermo Fisher Scientific has introduced the enhanced Thermo Scientific™ Vanquish™ Charged Aerosol Detector (CAD) P Series, an innovation to improve the analysis of the most complex samples, even those with analytes that do not possess chromophores.

Amsbio introduces iPSC kits for rapid, scalable and reproducible neural cell differentiation, enhancing flexibility for disease modeling and drug screening.

Nicoya acquires Applied Photophysics, boosting biopharma capabilities with advanced analytical tools for protein-based drug discovery.

CN Bio introduces new animal MPS models to improve drug safety and predict human toxicity in preclinical drug testing.

DEBRA Research and Dermaliq partner to advance cutaneous drug delivery for improved wound healing and therapies in EB.